Crime Bribery

More

  • Elon Musk questions Air Force ethics

    SpaceX CEO Elon Musk questions how the Air Force awarded rocket contracts to a competitor. CNBC's Eamon Javers reports.

  • GSK executives charged with bribery: Report

    Chinese police have charged GlaxoSmithKline executives who have been under investigation for allegedly bribing doctors and Chinese officials, reports CNBC's Eunice Yoon.

  • GSK China head faces bribery allegations

    CNBC's Eunice Yoon reports Chinese police say the former China head of drugmaker GlaxoSmithKine ordered employees to commit bribery, generating billions of dollars in illegal revenue.

  • An employee of British drug firm GlaxoSmithKline (GSK) enters their office headquarters in Shanghai.

    Chinese police on Wednesday said they had charged the British former China head of drugmaker GlaxoSmithKline and other colleagues with corruption, after a 10- month probe found they paid billions of yuan in bribes to doctors and hospitals.

  • The funds were seized from the sale of a house purchased in 2005 that U.S. prosecutors say are traceable to corruption during the reign of South Korea's former President Chun Doo-hwan.

  • Former New Orleans Mayor Ray Nagin.

    Former New Orleans Mayor Ray Nagin was convicted Wednesday on charges that he accepted bribes, free trips and other gratuities from contractors.

  • Alcoa pays $384 million to settle bribery cases

    CNBC's Morgan Brennan reports Alcoa will pay $384 million to settle bribery cases with the SEC & DOJ. Alcoa is charged with violating the Foreign Corrupt Practices Act.

  • Wal-Mart shakeup, not totally unexpected: Pro

    Stacey Widlitz, CNBC retail analyst, and Chris Horvers, JPMorgan retail-hardlines analyst, weigh in on Wal-Mart Mike Duke's successor Doug McMillon as new CEO.

  • Qatar World Cup bribery claims examined

    Mel Goldberg, senior partner at Mel Goldberg Law, discusses FIFA's investigation on corruption and bribery claims regarding Qatar's successful bid to host the World Cup in 2022.

  • Authorities are investigating British drugmaker GlaxoSmithKline for violations of US anti-bribery laws in China after Chinese government officials accused the company of bribing doctors.

  • The U.K.'s Serious Organised Crime Agency (Soca) has been ordered to make public a list of over 100 companies and individuals who hired corrupt private detectives. A government committee warned Soca that if it did publish the list by Monday, it would be forced to do so instead.

  • An internal exam of JPMorgan's hiring practices in Asia is looking at the employment of about 200 people for possible instances of illegal nepotism, a source said.

  • Wal-Mart CEO: Can't comment on Mexico bribery investigation

    Wal-Mart's CEO Mike Duke spoke to CNBC's Maria Bartiromo about the financial impact of the Mexican bribery allegations and says he "will take the appropriate actions; doing the right thing is a part of working at Wal-Mart."

  • China's 'trial of the century' underway

    Disgraced Chinese politician Bo Xilai faces charges of bribery, corruption and abuse of power in a move billed by the government as a fight against corruption, reports CNBC's Eunice Yoon.

  • Does JPM have a target on its back?

    Federal authorities are investigating JPMorgan's hiring of children of influential Chinese officials to help the bank win lucrative business deals. CNBC's Kayla Tausche has the details. And Andrew Stoltmann of Stoltmann Law Offices; and Thomas Curran, Peckar & Abramson, join to discuss the China bribery probe.

  • Glaxo's problems may go beyond the sales practices that are currently at the center of a bribery and corruption scandal in China. They may extend to its Shanghai research and development center.

  • 'Bribe is always a bribe' in GSK allegations

    Jonathan Russell, senior associate at Alaco, questions if GSK's action against bribery is being seen on the ground.

  • GlaxoSmithKline Shanghai headquarters

    GlaxoSmithKline CEO Andrew Witty will detail this week what action the drugmaker is taking in response to allegations of bribery against it in China, sources said.

  • China GSK crackdown unnerves business community

    China detained and questioned an executive of GlaxoSmithKline, amid an ongoing bribery investigation, reports CNBC's Eunice Yoon.

  • Is China 'unfairly targeting' multinationals?

    Willy Lam, professor at the Chinese University of Hong Kong, says the GSK corruption claim in China appears to be part of a large well-orchestrated campaign against multinationals